Denise Morris

Drug Safety Research Unit, Southampton, UK, United Kingdom

Poster(s):

• ((SLC-053)) (SLC-053) Risk of Venous Thrombosis With Thrombocytopenia Syndrome After Vaccination With AZD1222: A European VAC4EU Post-Authorisation Safety Study
  Tuesday, August 26, 2025

  12:15 PM - 1:15 PM ET

• ((SLC-054)) (SLC-054) Risk factors for myocarditis/pericarditis following mRNA-1273 vaccination: interim analysis of a VAC4EU case-cohort study
  Tuesday, August 26, 2025

  12:15 PM - 1:15 PM ET

• ((SLC-055)) (SLC-055) Clinical course and outcomes of myocarditis/pericarditis cases following mRNA-1273 vaccination compared to cases not following COVID-19 vaccination: interim analysis of a VAC4EU cohort study
  Tuesday, August 26, 2025

  12:15 PM - 1:15 PM ET

• ((A-332)) (A-332) Monitoring safety of Moderna COVID-19 vaccines in pregnancy: a multi-database study in Denmark, Norway, Spain and the United Kingdom. A regulator-mandated postauthorisation safety study in the VAC4EU network (EUPAS44450).
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• ((A-339)) (A-339) 2024 interim results from the VAC4EU post-authorisation safety study (PASS) for the Pfizer-BioNTech COVID-19 vaccine (Comirnaty®) in Europe
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• ((C-253)) (C-253) Active and Passive Safety Surveillance in Children Receiving Fluenz® Tetra Vaccination in England During Influenza Seasons - from 2014/2015 to 2022/2023
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET